TrialClinical genitourinary cancer2021

A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and Pembrolizumab Combination Therapy in Patients with Advanced Renal Cell Carcinoma.

Simon Chowdhury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.